Common Sense Oncology: outcomes that matterChristopher M. Booth, Bishal Gyawali, Ajay Aggarwal et al.|The Lancet Oncology|2023Cited by 101
Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paperNicolò Matteo Luca Battisti, Alistair Ring, Nienke A. de Glas et al.|Therapeutic Advances in Medical Oncology|2018Cited by 61